Certified Diabetes Care and Education Specialist (CDCES) Practice Exam

The recommendation for considering metabolic surgery, particularly in patients with type 2 diabetes, is specifically aimed at individuals with a body mass index (BMI) greater than 35 who have demonstrated difficulty in achieving adequate glycemic control. This is because obesity is a significant risk factor for the progression and severity of type 2 diabetes, and traditional weight loss methods may not always be effective for every patient. When a patient's BMI exceeds 35, it indicates a higher level of obesity which is often associated with increased health risks and complications related to diabetes management. This population may benefit from metabolic surgery, also known as bariatric surgery, as it can lead not only to substantial weight loss but also to significant improvements in glycemic control, reduction in diabetes-related complications, and even remission of the disease in some cases. The other criteria mentioned, while they may have some relevance in discussions around metabolic health and obesity, do not encompass the specific focus of the ADA guidelines on BMI and glycemic control, making the understanding of these guidelines essential for effective patient management and treatment planning.